Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

HIV Infection

Free Subscription 19.08.2019 13 AIDS 4 AIDS Res Hum Retroviruses 2 Antimicrob Agents Chemother 1 Br J Dermatol 5 Clin Infect Dis 5 J Acquir Immune Defic Syndr 2 J Infect Dis 4 J Virol 2 Lancet 1 Lancet Glob Health 1 N Engl J Med 2 Nature 1 Neurology 1 Pediatr Infect Dis J 1 PLoS Med 8 PLoS One 1 PLoS Pathog 2 Science 1 Vaccine

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AIDS

1. HARPER GW, Wagner RL, Popoff E, Reisner SL, et al
   Psychological resilience among transfeminine adolescents and emerging adults living with HIV.
   AIDS. 2019;33 Suppl 1:S53-S62.
   PubMed     Text format     Abstract available
   
   
2. HARRISON SE, Li X, Vermund SH
   From surviving to thriving: the role of resilience in meeting global HIV goals.
   AIDS. 2019;33 Suppl 1:S1-S4.
   PubMed     Text format     Abstract available
   
   
3. ROTHERAM-BORUS MJ, Christodoulou J, Hayati Rezvan P, Comulada WS, et al
   Maternal HIV does not affect resiliency among uninfected/HIV exposed South African children from birth to 5 years of age.
   AIDS. 2019;33 Suppl 1:S5-S16.
   PubMed     Text format     Abstract available
   
   
4. MALEE KM, Kerr S, Paul R, Puthanakit T, et al
   Emotional and behavioral resilience among children with perinatally acquired HIV in Thailand and Cambodia.
   AIDS. 2019;33 Suppl 1:S17-S27.
   PubMed     Text format     Abstract available
   
   
5. KUO C, LoVette A, Pellowski J, Harrison A, et al
   Resilience and psychosocial outcomes among South African adolescents affected by HIV.
   AIDS. 2019;33 Suppl 1:S29-S34.
   PubMed     Text format     Abstract available
   
   
6. QIAO S, Ingram L, Deal ML, Li X, et al
   Resilience resources among African American women living with HIV in Southern United States.
   AIDS. 2019;33 Suppl 1:S35-S44.
   PubMed     Text format     Abstract available
   
   
7. BARNIGHAUSEN KE, Matse S, Kennedy CE, Lejeune CL, et al
   'This is mine, this is for me': preexposure prophylaxis as a source of resilience among women in Eswatini.
   AIDS. 2019;33 Suppl 1:S45-S52.
   PubMed     Text format     Abstract available
   
   
8. ZHAO Q, Mao Y, Li X, Qiao S, et al
   Psychosocial correlates of health-related quality of life among people living with HIV in China: the mediating role of resilience.
   AIDS. 2019;33 Suppl 1:S63-S70.
   PubMed     Text format     Abstract available
   
   
9. KATZ IT, Bogart LM, Dietrich JJ, Leslie HH, et al
   Understanding the role of resilience resources, antiretroviral therapy initiation, and HIV-1 RNA suppression among people living with HIV in South Africa: a prospective cohort study.
   AIDS. 2019;33 Suppl 1:S71-S79.
   PubMed     Text format     Abstract available
   
   
10. HARRISON SE, Li X, Zhang J, Zhao J, et al
    A cluster randomized controlled trial to evaluate a resilience-based intervention for caregivers of HIV-affected children in China.
    AIDS. 2019;33 Suppl 1:S81-S91.
    PubMed     Text format     Abstract available
    
    
11. VREEMAN RC, Nyandiko WM, Marete I, Mwangi A, et al
    Evaluating a patient-centred intervention to increase disclosure and promote resilience for children living with HIV in Kenya.
    AIDS. 2019;33 Suppl 1:S93-S101.
    PubMed     Text format     Abstract available
    
    
12. COSTINIUK CT, Jenabian MA
    Cannabinoids and inflammation: Implications for People Living with HIV.
    AIDS. 2019 Aug 12. doi: 10.1097/QAD.0000000000002345.
    PubMed     Text format     Abstract available
    
    
13. MONTGOMERY ET, Roberts ST, Nel A, Malherbe M, et al
    Social Harms in Female-INITIATED hiv prevention method RESEARCH: state of the evidence.
    AIDS. 2019 Aug 12. doi: 10.1097/QAD.0000000000002346.
    PubMed     Text format     Abstract available
    
    

    
    AIDS Res Hum Retroviruses

14. KAFANDO A, Serhir B, Doualla-Bell F, Fournier E, et al
    A short-term assessment of nascent HIV-1 transmission clusters among newly diagnosed individuals using envelope sequence-based phylogenetic analyses.
    AIDS Res Hum Retroviruses. 2019 Aug 13. doi: 10.1089/AID.2019.0142.
    PubMed     Text format     Abstract available
    
    
15. GOJANOVICH GS, Shikuma C, Milne C, LiButti DE, et al
    Subcutaneous Adipocyte Adenosine Triphosphate Levels in HIV Infected Patients.
    AIDS Res Hum Retroviruses. 2019 Aug 13. doi: 10.1089/AID.2019.0121.
    PubMed     Text format     Abstract available
    
    
16. FLORIS-MOORE M, Edmonds A, Napravnik S, Adimora AA, et al
    Computerized Adjudication of Coronary Heart Disease Events using the Electronic Medical Record in HIV Clinical Research: Possibilities and Challenges Ahead.
    AIDS Res Hum Retroviruses. 2019 Aug 13. doi: 10.1089/AID.2019.0036.
    PubMed     Text format     Abstract available
    
    
17. CASTILHO JL, Turner M, Shepherd BE, Koethe JR, et al
    CD4/CD8 ratio and CD4 nadir predict mortality following non-communicable disease diagnosis in adults living with HIV.
    AIDS Res Hum Retroviruses. 2019 Aug 13. doi: 10.1089/AID.2019.0064.
    PubMed     Text format     Abstract available
    
    

    
    Antimicrob Agents Chemother

18. WANG Q, Modongo C, Allender C, Engelthaler DM, et al
    Utility of targeted, amplicon-based deep sequencing to detect resistance to first-line tuberculosis drugs in Botswana.
    Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.00982.
    PubMed     Text format     Abstract available
    
    
19. SALINGER DH, Subramoney V, Everitt D, Nedelman JR, et al
    Population Pharmacokinetics of Pretomanid.
    Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.00907.
    PubMed     Text format     Abstract available
    
    

    
    Br J Dermatol

20. DENG PH, Wang CJ, Armstrong AW
    An Association between Hidradenitis Suppurativa and HIV.
    Br J Dermatol. 2019 Aug 13. doi: 10.1111/bjd.18433.
    PubMed     Text format     Abstract available
    
    

    
    Clin Infect Dis

21. GRABOVAC I, Veronese N, Stefanac S, Haider S, et al
    Human Immunodeficiency Virus Infection and Diverse Physical Health Outcomes: An Umbrella Review of Meta-analyses of Observational Studies.
    Clin Infect Dis. 2019 Aug 11. pii: 5537328. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
22. BRITES C, Miranda F, Luz E, Netto EM, et al
    Early and Successful cART Normalizes Survival Time in HIV-HTLV-1 Coinfected Patients.
    Clin Infect Dis. 2019 Aug 13. pii: 5549137. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
23. MARCUS JL, Snowden JM, Murray Horwitz ME, Toh S, et al
    Use of Intrauterine Devices and Risk of HIV Acquisition among Insured Women in the U.S.
    Clin Infect Dis. 2019 Aug 15. pii: 5550162. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
24. TREVILLYAN JM, Moser C, Currier JS, Sallam T, et al
    Immune Biomarkers in the Prediction of Future Myocardial Infarction in People with HIV.
    Clin Infect Dis. 2019 Aug 15. pii: 5550255. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
25. STEVENS ER, Nucifora KA, Hagan H, Jordan AE, et al
    Cost-effectiveness of direct anti-viral agents for hepatitis C virus infection and a combined intervention of syringe access and medication assisted therapy for opioid use disorders in an injection drug use population.
    Clin Infect Dis. 2019 Aug 11. pii: 5546014. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    J Acquir Immune Defic Syndr

26. BRAHME R, Godbole S, Sonawale S, Kadu C, et al
    Declining Trends in HIV Prevalence Among Women Attending Antenatal Care Clinics Obfuscate the Continued Vulnerability of Adolescent Girls in Maharashtra, India (2005-2017).
    J Acquir Immune Defic Syndr. 2019;82:e13-e17.
    PubMed     Text format    
    
    
27. LACOURSE SM, Wagner AD, Cranmer LM, Copeland A, et al
    Brief Report: High Programmatic Isoniazid Preventive Therapy (IPT) Use in Pregnancy Among HIV-Infected Women.
    J Acquir Immune Defic Syndr. 2019;82:41-45.
    PubMed     Text format     Abstract available
    
    
28. BRENNAN AT, Bonawitz R, Gill CJ, Thea DM, et al
    A Meta-analysis Assessing Diarrhea and Pneumonia in HIV-Exposed Uninfected Compared With HIV-Unexposed Uninfected Infants and Children.
    J Acquir Immune Defic Syndr. 2019;82:1-8.
    PubMed     Text format     Abstract available
    
    
29. HEVEY MA, Presti RM, O'Halloran JA, Larson L, et al
    Mortality After Cryptococcal Infection in the Modern Antiretroviral Therapy Era.
    J Acquir Immune Defic Syndr. 2019;82:81-87.
    PubMed     Text format     Abstract available
    
    
30. KERSCHBERGER B, Ntshalintshali N, Mpala Q, Diaz Uribe PA, et al
    Field Suitability and Diagnostic Accuracy of the Biocentric Open Real-Time PCR Platform for Dried Blood Spot-Based HIV Viral Load Quantification in Eswatini.
    J Acquir Immune Defic Syndr. 2019;82:96-104.
    PubMed     Text format     Abstract available
    
    

    
    J Infect Dis

31. AKDAG D, Knudsen AD, Thudium RF, Kirkegaard-Klitbo DM, et al
    Increased risk of anemia, neutropenia and thrombocytopenia in people with HIV and well-controlled viral replication.
    J Infect Dis. 2019 Aug 15. pii: 5550247. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
32. CHOI YH, Perez-Cuevas MB, Kodani M, Zhang X, et al
    Feasibility of Hepatitis B Vaccination by Microneedle Patch: Cellular and Humoral Immunity Studies in Rhesus Macaques.
    J Infect Dis. 2019 Aug 13. pii: 5549399. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    J Virol

33. ANDERSON-DANIELS J, Singh PK, Sowd GA, Li W, et al
    Dominant negative MA-CA fusion protein is incorporated into HIV-1 cores and inhibits nuclear entry of viral preintegration complexes.
    J Virol. 2019 Aug 14. pii: JVI.01118-19. doi: 10.1128/JVI.01118.
    PubMed     Text format     Abstract available
    
    
34. PALERMO E, Acchioni C, Di Carlo D, Zevini A, et al
    Activation of latent HIV-1 T cell reservoirs with a combination of innate immune and epigenetic regulators.
    J Virol. 2019 Aug 14. pii: JVI.01194-19. doi: 10.1128/JVI.01194.
    PubMed     Text format     Abstract available
    
    
35. ALMOND N, Berry N, Stebbings R, Preston M, et al
    Vaccination of macaques with DNA followed by adenoviral vectors encoding SIV gag alone delays infection by repeated mucosal challenge with SIV.
    J Virol. 2019 Aug 14. pii: JVI.00606-19. doi: 10.1128/JVI.00606.
    PubMed     Text format     Abstract available
    
    
36. KUTLUAY SB, Emery A, Penumutchu S, Townsend D, et al
    Genome wide analysis of hnRNP binding to HIV-1 RNA reveals a key role for hnRNP H1 in alternative viral mRNA splicing.
    J Virol. 2019 Aug 14. pii: JVI.01048-19. doi: 10.1128/JVI.01048.
    PubMed     Text format     Abstract available
    
    

    
    Lancet

37. SATOH S, Boyer E
    HIV in South Africa.
    Lancet. 2019;394:467.
    PubMed     Text format    
    
    
38. NOGUCHI LM, Simelela PN
    How should we listen to ECHO?
    Lancet. 2019;394:275-276.
    PubMed     Text format    
    
    

    
    Lancet Glob Health

39. SMOLAK A, Chemaitelly H, Hermez JG, Low N, et al
    Epidemiology of Chlamydia trachomatis in the Middle East and north Africa: a systematic review, meta-analysis, and meta-regression.
    Lancet Glob Health. 2019;7:e1197-e1225.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

40. AHUKA-MUNDEKE S, Casey RM, Harris JB, Dixon MG, et al
    Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak - Preliminary Report.
    N Engl J Med. 2018 Feb 14. doi: 10.1056/NEJMoa1710430.
    PubMed     Text format     Abstract available
    
    

    
    Nature

41. GEWIN V
    A disadvantaged background doesn't have to be a barrier to success.
    Nature. 2019;566:415-417.
    PubMed     Text format    
    
    
42. CYRANOSKI D
    The CRISPR-baby scandal: what's next for human gene-editing.
    Nature. 2019;566:440-442.
    PubMed     Text format    
    
    

    
    Neurology

43. GALLA KM, Cameron-Smith E, Bares SH, Braun A, et al
    Teaching NeuroImages: Presentation of diffuse large B-cell lymphoma with bilateral sequential oculomotor neuropathy.
    Neurology. 2018;91:e92-e93.
    PubMed     Text format    
    
    

    
    Pediatr Infect Dis J

44. ATWELL JE, Thumar B, Formica MA, Robinson LJ, et al
    Hypergammaglobulinemia and Impaired Transplacental Transfer of Respiratory Syncytial Virus Antibody in Papua New Guinea.
    Pediatr Infect Dis J. 2019;38:e199-e202.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Med

45. GUPTA A, Hughes MD, Garcia-Prats AJ, McIntire K, et al
    Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons.
    PLoS Med. 2019;16:e1002882.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

46. RABEN D, Sullivan AK, Mocroft A, Kutsyna G, et al
    Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study - 2012 - 2015.
    PLoS One. 2019;14:e0220108.
    PubMed     Text format     Abstract available
    
    
47. MANDELBROT L, Ceccaldi PF, Duro D, Le M, et al
    Placental transfer and tissue accumulation of dolutegravir in the ex vivo human cotyledon perfusion model.
    PLoS One. 2019;14:e0220323.
    PubMed     Text format     Abstract available
    
    
48. FRONTEAU C, Pare M, Benoit P, Tollec S, et al
    What do adult outpatients included in clinical trials know about the investigational drugs being assessed: A cross-sectional study in France.
    PLoS One. 2019;14:e0220383.
    PubMed     Text format     Abstract available
    
    
49. KANSIIME S, Mwesigire D, Mugerwa H
    Prevalence of non-communicable diseases among HIV positive patients on antiretroviral therapy at joint clinical research centre, Lubowa, Uganda.
    PLoS One. 2019;14:e0221022.
    PubMed     Text format     Abstract available
    
    
50. AWORI Q, Li PS, Lee RK, Ouma D, et al
    Use of topical versus injectable anaesthesia for ShangRing circumcisions in men and boys in Kenya: Results from a randomized controlled trial.
    PLoS One. 2019;14:e0218066.
    PubMed     Text format     Abstract available
    
    
51. GREENBLATT R, Bacchetti P, Boylan R, Kober K, et al
    Genetic and clinical predictors of CD4 lymphocyte recovery during suppressive antiretroviral therapy: Whole exome sequencing and antiretroviral therapy response phenotypes.
    PLoS One. 2019;14:e0219201.
    PubMed     Text format     Abstract available
    
    
52. FAUK NK, Merry MS, Putra S, Sigilipoe MA, et al
    Perceptions among transgender women of factors associated with the access to HIV/AIDS-related health services in Yogyakarta, Indonesia.
    PLoS One. 2019;14:e0221013.
    PubMed     Text format     Abstract available
    
    
53. DE BRESSER I, Remers TEP, Wieland MWM, Prawiranegara R, et al
    Prioritizing HIV/AIDS prevention strategies in Bandung, Indonesia: A cost analysis of three different HIV/AIDS interventions.
    PLoS One. 2019;14:e0221078.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Pathog

54. QIN K, Boppana S, Du VY, Carlson JM, et al
    CD8 T cells targeting adapted epitopes in chronic HIV infection promote dendritic cell maturation and CD4 T cell trans-infection.
    PLoS Pathog. 2019;15:e1007970.
    PubMed     Text format     Abstract available
    
    

    
    Science

55. COHEN J
    Giant prevention study has sobering message.
    Science. 2019;363:1132.
    PubMed     Text format    
    
    
56. COHEN J
    Cancer therapy returns to original target: HIV.
    Science. 2019;365:530.
    PubMed     Text format    
    
    

    
    Vaccine

57. WORLD HEALTH ORGANIZATION
    Measles vaccines: WHO position paper, April 2017 - Recommendations.
    Vaccine. 2019;37:219-222.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: